In this article, Gregory Vistnes outlines why Antitrust Agencies care about clinical integration, an issue that might seem primarily an issue of concern to the healthcare community and not antitrust enforcers, and how the agencies typically evaluate the competitive significance of clinical integration.
New research analyzes the impact of hazardous waste management on US economic growth
Improper management of hazardous waste can contaminate soil and drinking water, release toxic air pollutants, and create serious health risks for exposed...